D
Altimmune, Inc. ALT
$3.93 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -95.11% -95.12% -95.31% -81.36% 604.94%
Total Other Revenue -- -- -- -- --
Total Revenue -95.11% -95.12% -95.31% -81.36% 604.94%
Cost of Revenue -6.79% 9.32% 24.97% 16.58% 11.43%
Gross Profit 6.32% -9.94% -25.75% -16.98% -10.72%
SG&A Expenses 10.07% 14.43% 15.60% 14.75% 12.31%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -3.38% 10.41% 22.94% 16.20% 11.61%
Operating Income 2.99% -10.90% -23.54% -16.52% -11.04%
Income Before Tax 12.75% 1.99% -7.48% -31.93% -24.34%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 13.42% 2.72% -7.48% -31.93% -24.64%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 13.42% 2.72% -7.48% -31.93% -24.64%
EBIT 2.99% -10.90% -23.54% -16.52% -11.04%
EBITDA 2.72% -11.30% -23.98% -17.29% -11.50%
EPS Basic 27.25% 21.09% 18.58% -1.24% 0.53%
Normalized Basic EPS 15.61% 8.25% 6.50% 12.60% 13.80%
EPS Diluted 27.25% 21.09% 18.58% -0.69% 1.21%
Normalized Diluted EPS 15.61% 8.25% 6.50% 12.60% 13.80%
Average Basic Shares Outstanding 17.95% 23.65% 33.43% 32.66% 26.82%
Average Diluted Shares Outstanding 17.95% 23.65% 33.43% 32.66% 26.82%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --